Clinical Trials Directory

Trials / Unknown

UnknownNCT00155194

Evaluation of Immune Function in Biliary Atresia Children With Prolonged Jaundice

Impaired T-Lymphocyte Proliferative Function in Biliary Atresia Children With Prolonged Jaundice

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (planned)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
1 Year
Healthy volunteers
Not accepted

Summary

Null hypothesis of this study: Biliary atresia patients with cholestatic jaundice do not have systemic immunity defect.

Detailed description

Biliary atresia patients with cholestatic jaundice were noted to have increased incidence of infectious complications. Previous animal models of bile duct ligation with acute jaundice ever demonstrated impairment of both humoral and cellular immune function. We performed the immunity study in biliary atresia patients due to the lack of comprehensive systemic immunity study in pediatric cholestatic model. Systemic humoral immunity (total serum IgG, IgA, IgM, C3 and C4), specific cellular immunity (lymphocyte classification, mitogen response, cytokines level after PHA stimulation test), and non-specific cellular immunity (absolute neutrophil count, PMN CD11b/CD18 expression level, PMN superoxide release function, and PMN phagocytosis function) were tested. Association with serum bilirubin level, nutritional status and blood biochemical values were tested to see the relation between systemic immune function and cholestatic jaundice.

Conditions

Timeline

Start date
2004-04-01
First posted
2005-09-12
Last updated
2005-09-12

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT00155194. Inclusion in this directory is not an endorsement.